Introduction of rotavirus vaccination in Palestine: An evaluation of the costs, impact, and cost-effectiveness of ROTARIX and ROTAVAC

Feb 05, 2020

Published Research

Graph demonstrating cost-effectiveness acceptability curve - government perspective

Rotavirus vaccines are cost-effective. But a new study by PATH and partners helps policymakers decide among the options using important variables beyond price. 

This example demonstrates ways in which countries should consider systematically assessing multiple aspects beyond vaccine price when comparing the health and economic value of several products, especially as new vaccine options become available.

Read the full study